Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Nehmiz, Gerhard
23  Ergebnisse:
Personensuche X
?
1

Bayesian Phase II optimization for time-to-event data based..:

Bertsche, Anja ; Fleischer, Frank ; Beyersmann, Jan.
Statistical Methods in Medical Research.  28 (2017)  4 - p. 1272-1289 , 2017
Link: https://doi.org/10.1177/..
 
?
2

An open-label study of the pharmacokinetics and pharmacodyn..:

Eriksson, Bengt I. ; Mikuska, Zsolt ; Feuring, Martin...
Thrombosis Research.  144 (2016)  - p. 158-164 , 2016
Link: https://doi.org/10.1016/..
 
?
3

The predictive distribution of the residual variability in ..:

Bertsche, Anja ; Nehmiz, Gerhard ; Beyersmann, Jan.
Biometrical Journal.  58 (2016)  4 - p. 797-809 , 2016
Link: https://doi.org/10.1002/..
 
?
4

Faldaprevir combined with peginterferon alfa-2a and ribavir..:

Sulkowski, Mark S. ; Bourlière, Marc ; Bronowicki, Jean-Pierre...
Hepatology.  57 (2013)  6 - p. 2155-2163 , 2013
Link: https://doi.org/10.1002/..
 
?
5

Oral bioavailability of dabigatran etexilate (Pradaxa®) aft..:

Härtter, Sebastian ; Sennewald, Regina ; Nehmiz, Gerhard.
British Journal of Clinical Pharmacology.  75 (2013)  4 - p. 1053-1062 , 2013
Link: https://doi.org/10.1111/..
 
?
6

Response to the letter by Dr Chin and co‐workers:

Härtter, Sebastian ; Koenen‐Bergmann, Michael ; Sharma, Ashish...
British Journal of Clinical Pharmacology.  75 (2013)  2 - p. 571-571 , 2013
Link: https://doi.org/10.1111/..
 
?
7

Faldaprevir combined with pegylated interferon alfa-2a and ..:

Sulkowski, Mark S. ; Asselah, Tarik ; Lalezari, Jacob...
Hepatology.  57 (2013)  6 - p. 2143-2154 , 2013
Link: https://doi.org/10.1002/..
 
?
8

Empagliflozin (BI 10773), a Potent and Selective SGLT2 Inhi..:

Seman, Leo ; Macha, Sreeraj ; Nehmiz, Gerhard...
Clinical Pharmacology in Drug Development.  2 (2013)  2 - p. 152-161 , 2013
Link: https://doi.org/10.1002/..
 
?
9

Decrease in the oral bioavailability of dabigatran etexilat..:

Härtter, Sebastian ; Koenen‐Bergmann, Michael ; Sharma, Ashish...
British Journal of Clinical Pharmacology.  74 (2012)  3 - p. 490-500 , 2012
Link: https://doi.org/10.1111/..
 
?
10

Efficacy of the Protease Inhibitor BI 201335, Polymerase In..:

Zeuzem, Stefan ; Asselah, Tarik ; Angus, Peter...
Gastroenterology.  141 (2011)  6 - p. 2047-2055 , 2011
Link: https://doi.org/10.1053/..
 
?
11

Dabigatran With or Without Concomitant Aspirin Compared Wit..:

Ezekowitz, Michael D. ; Reilly, Paul A. ; Nehmiz, Gerhard...
The American Journal of Cardiology.  100 (2007)  9 - p. 1419-1426 , 2007
Link: https://doi.org/10.1016/..
 
?
12

Book Review: Statistical Concepts and Applications in Clini..:

Nehmiz, Gerhard
Biometrical Journal.  49 (2007)  5 - p. 790-790 , 2007
Link: https://doi.org/10.1002/..
 
?
13

Antiviral efficacy of NS3-serine protease inhibitor BILN-20..:

Reiser, Markus ; Hinrichsen, Holger ; Benhamou, Yves...
Hepatology.  41 (2005)  4 - p. 832-835 , 2005
Link: https://doi.org/10.1002/..
 
?
14

Pharmacokinetic Profile of the Oral Direct Thrombin Inhibit..:

Stangier, Joachim ; Eriksson, Bengt I. ; Dahl, Ola E....
The Journal of Clinical Pharmacology.  45 (2005)  5 - p. 555-565 , 2005
Link: https://doi.org/10.1177/..
 
?
15

Pharmacokinetics and pharmacodynamics of terbogrel, a combi..:

Guth, Brian D. ; Narjes, Hans ; Schubert, Hans‐Dieter...
British Journal of Clinical Pharmacology.  58 (2004)  1 - p. 40-51 , 2004
Link: https://doi.org/10.1111/..
 
1-15